Corcept Therapeutics (CORT) Current Deferred Revenue (2012 - 2015)
Corcept Therapeutics (CORT) reported Current Deferred Revenue of $158000.0 for Q4 2015, up 378.79% on a YoY basis from $33000.0 in Q4 2014, and up 100.0% sequentially from $79000.0 in Q3 2015.
Corcept Therapeutics (CORT) Current Deferred Revenue (2012 - 2015) Analysis & Trends
Corcept Therapeutics (CORT) has 4 years of Current Deferred Revenue data on file, last reported at $158000.0 in Q4 2015.
- For the quarter ending Q4 2015, Current Deferred Revenue rose 378.79% year-over-year to $158000.0; the trailing twelve-month figure through Dec 2015 stood at $158000.0 (up 378.79% YoY), and the FY2015 full-year result was $158000.0, up 378.79% from the prior year.
- Current Deferred Revenue grew to $158000.0 in Q4 2015, from $79000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $158000.0 in Q4 2015 to a low of $16000.0 in Q4 2012.
- A 4-year average of $49400.0 and a median of $37000.0 in 2013 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue plunged 61.84% in 2014 and jumped 378.79% in 2015, its largest moves.
- Tracing CORT's Current Deferred Revenue over 4 years: stood at $16000.0 in 2012, then jumped by 56.25% to $25000.0 in 2013, then soared by 32.0% to $33000.0 in 2014, then jumped by 378.79% to $158000.0 in 2015.
- Business Quant data shows CORT's Current Deferred Revenue at $158000.0 in Q4 2015, $79000.0 in Q3 2015, and $37000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Corcept Therapeutics | 9.99 Bn | 9.65 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 158,000.00 |
| Sep 30, 2015 | 79,000.00 |
| Jun 30, 2015 | 37,000.00 |
| Mar 31, 2015 | 55,000.00 |
| Dec 31, 2014 | 33,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 44,000.00 |
| Mar 31, 2014 | 29,000.00 |
| Dec 31, 2013 | 25,000.00 |
| Sep 30, 2013 | 55,000.00 |
| Jun 30, 2013 | 37,000.00 |
| Mar 31, 2013 | 76,000.00 |
| Dec 31, 2012 | 16,000.00 |
| Sep 30, 2012 | 21,000.00 |
| Jun 30, 2012 | 26,000.00 |